Abstract
Clinical hematology analyzer analysis is one of the oldest and most important
sectors of clinical laboratory analysis. The hematology instrument and reagent
market is centered around a group of instruments called hematology analyzers.
The term clinical hematology analyzer usually refers to an automated
instrument for determining the presence, number and type of cellular elements
in easily collected body fluids, such as blood. However, it is not necessarily
limited to these determinations. The hematology analysis always includes
determination of non-cellular parameters in blood, such as hemoglobin and
hematocrit. Other closely related areas of clinical interest are coagulation
and flow cytometry. In fact, traditional specialization barriers, such as
microbiology, hematology, blood banking, immunology and even anatomical
pathology are rapidly fading both operationally and instrumentally. But for
the sake of defining the subject to a reasonable size, the more traditional
scope of clinical hematology analyzer will be the focus of this examination.
The purpose of this TriMark Publications report is to describe the specific
segments of the global clinical hematology analyzer instrumentation and
reagent marketplace. The review covers those segments that are highly active
in terms of innovation and growth. Specifically, this study examines the
markets for small-lab, as well as highly-automated large-lab, platforms and
accessory equipment, such as reagents, supplies and add-on equipment from
original equipment manufacturers.
View Cart
